Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Jun 2026 for Galectin Therapeutics INC, €301k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Jamil Khurram: trading record in brief
This profile gathers the share dealings of Jamil Khurram in Galectin Therapeutics Inc. In total, 2 filings cover trades dated from 23 June 2026 to 26 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 26 June 2026: a transaction of €301k, in Galectin Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jamil Khurram
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
68,287 shares@ US$5.000.12% mcap51.8% of flowCommon StockSEC144:0001972481-26-000216
8,125 shares@ US$3.13850.0074% mcap3.9% of flowCommon StockSEC144:0001972481-26-000208
2 of 2 declarations
